Board adds Lorinda Burgess; director equity grants fully vested

ANGIODYNAMICS INC

Lorinda Burgess appointed as Class III director effective July 19, 2023, expanding board to nine members.
Burgess brings 35+ years experience, including 15+ years at Medtronic as Vice President of Finance, Americas Region.
Burgess was appointed to the Audit Committee and Compensation Committee of the Board.
Non-employee director annual equity grants changed to be fully vested at time of grant.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lorinda Burgess

Class III Director

ANGO · ANGIODYNAMICS INC

Effective: 2023-07-19
Filed: July 24, 2023, 7:59 PM ET

On July 19, 2023, the board of directors (the “Board”) of AngioDynamics, Inc. (“AngioDynamics”) approved an increase in the size of the Board to a total of nine directors and appointed Lorinda Burgess as a Class III director of AngioDynamics, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lorinda Burgess was appointed as Class III Director at ANGIODYNAMICS INC.

Action: appointed
Role: Class III Director

Exact text from the filing

On July 19, 2023, the board of directors (the “Board”) of AngioDynamics, Inc. (“AngioDynamics”) approved an increase in the size of the Board to a total of nine directors and appointed Lorinda Burgess as a Class III director of AngioDynamics, effective immediately.

View on SEC.gov

ANGIODYNAMICS INC filing history →

Source: SEC EDGAR

accession 0001140361-23-035863

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.